San Francisco maintains low COVID cases while preparing vaccine transition after Johnson & Johnson pause

The San Francisco government meeting on July 4, 2025, focused on the city's ongoing response to the COVID-19 pandemic, highlighting current case statistics, vaccination efforts, and the transition of public health operations.

As of the meeting, San Francisco reported a total of 35,816 diagnosed COVID-19 cases, with a steady plateau in new cases since February. The city's case rate has remained low, with hospitalizations significantly reduced, currently down to just three COVID-positive patients at Zuckerberg San Francisco Hospital. This marks a notable improvement from previous months.

Vaccination efforts in San Francisco have progressed well, with 64% of eligible residents having received at least one vaccine dose, and 42% fully vaccinated. The city is currently administering an average of 10,400 vaccines per day, although this number has decreased due to a reduction in supply from vaccine manufacturers. The city anticipates that eligibility for vaccination will soon expand to include individuals aged 12 to 15, pending further approvals.

The meeting also addressed the transition of COVID-19 response operations back to the Department of Public Health (DPH). Officials emphasized a phased approach to this transition, which will be guided by specific milestones and resource needs. The goal is to ensure a smooth shift while maintaining ongoing public health services and managing expectations from the community and city departments.

Overall, the meeting underscored San Francisco's commitment to managing the pandemic effectively while preparing for a return to normal operations. The city remains focused on vaccination efforts and monitoring case trends as it navigates this critical phase of the public health response.